11. PATH-17. NOVEL DUAL HISTONE 3 K27M AND G34R POINT MUTATIONS IN A MIDLINE GLIOMA. (9th November 2020) Authors: Pan, Peter; Bale, Tejus; Miller, Alexandra; Ladanyi, Marc; Rosenblum, Marc; Haggiagi, Aya Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. PATH-32. CONCORDANCE FOR CDKN2A/B LOSS AND TERT MUTATION IN WHO 2021 CLASSIFICATION GRADE 3 MENINGIOMAS: A RETROSPECTIVE STUDY. (14th November 2022) Authors: Yuen, Carlen; Pan, Peter; Teasley, Damian; Miller, Michael; Sun, Yu; Canoll, Peter; Joanta-Gomez, Adela; Bargo, Alicia; Iwamoto, Fabio Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. RADT-19. CHEMORADIATION (CRT) TREATMENT WITH OR WITHOUT CONCURRENT TUMOR-TREATING FIELDS (TTFIELDS) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM). (14th November 2022) Authors: Cappelli, Louis; Kayne, Allison; Pan, Peter; Cordova, James; Huang, Jiayi; Wang, Tony; Alnahhas, Iyad; Shi, Wenyin Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Temporal attention is not affected by working memory load. (September 2020) Authors: Zanto, Theodore P.; Liu, Helen; Pan, Peter; Gazzaley, Adam Journal: Cortex Issue: Volume 130(2020) Page Start: 351 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗